Screener
Arcutis Biotherapeutics, Inc. ARQT Business Segments — Interest Expense, Nonoperating
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
| Line item | Three Months Ended June 30, 2026 | Three Months Ended June 30, 2025 | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Income (loss) from operations | 16,429 | (14,611) | 7,340 | (39,140) |
| Other income (expense): | ||||
| Interest income | 2,279 | 2,076 | 4,554 | 4,613 |
| Interest expense | (3,406) | (3,029) | (7,774) | (6,011) |
| Other income (expense), net | (157) | 20 | (177) | 213 |
| Total other income (expense) | (1,284) | (933) | (3,397) | (1,185) |
| Income (loss) before income taxes | 15,145 | (15,544) | 3,943 | (40,325) |
| Provision for income taxes | 136 | 342 | 229 | 621 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Arcutis Biotherapeutics, Inc.'s business segments — interest expense, nonoperating?
- Arcutis Biotherapeutics, Inc. (ARQT) reported business segments — interest expense, nonoperating of $3.41M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s business segments — interest expense, nonoperating changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s business segments — interest expense, nonoperating increased by 12.4% year-over-year, from $3.03M to $3.41M.
- What is the long-term trend for Arcutis Biotherapeutics, Inc.'s business segments — interest expense, nonoperating?
- Over 3 years (2022 to 2025), Arcutis Biotherapeutics, Inc.'s business segments — interest expense, nonoperating has grown at a -8.3% compound annual growth rate (CAGR), from $15.65M to $12.08M.
- What does business segments — interest expense, nonoperating mean?
- Captures the costs associated with the segment's debt obligations and financing activities that are not related to core operations. This metric highlights the financial burden of the segment's capital structure.
Ask your AI about Arcutis Biotherapeutics, Inc.'s business segments — interest expense, nonoperating.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude